Precigen PGEN Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $7.48M+23.5% | $30.23M+2.4% | $14.32M-42.1% | $13.76M+43.2% | $6.06M-65.9% | ||
| $48.77M-34.3% | $67.62M-1.1% | $106.81M+2,635% | $45.99M+351% | $74.18M+172% | ||
| $26.4M+3,416% | $3.92M+323% | $580K+21.1% | $327K-36.0% | $751K-13.9% | ||
| —— | —— | —— | —— | —— | ||
| $101.67M+20.2% | $115.24M+12.5% | $129.6M+276% | $62.76M+165% | $84.6M+70.8% | ||
| $13.22M-9.9% | $13.76M-0.5% | $14.81M+9.4% | $14.7M+9.2% | $14.67M+16.2% | ||
| $15.23M-20.4% | $15.23M-20.4% | $15.23M-38.9% | $15.23M-38.9% | $19.14M-27.9% | ||
| $2.86M-30.8% | $3.18M-28.6% | $3.5M-26.7% | $3.82M-25.0% | $4.14M-89.3% | ||
| $138.63M+7.6% | $155.51M+7.0% | $171.26M+105% | $101.9M+39.3% | $128.79M-4.5% | ||
| $410K-25.3% | $517K-12.2% | $480K+17.9% | $413K+9.3% | $549K+34.9% | ||
| $21.1M-12.0% | $37.31M+73.4% | $32.07M+51.2% | $23.19M+0.7% | $23.99M-16.6% | ||
| —— | —— | —— | —— | —— | ||
| $118.39M+42.6% | $134.59M+166% | $129.4M+361% | $78.56M+162% | $83.02M+119% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| -$2.35B-9.5% | -$2.34B-12.0% | -$2.32B-11.9% | -$2.17B-6.1% | -$2.14B-7.9% | ||
| $20.24M+244% | $20.91M-45.7% | $41.87M-24.4% | -$36.78M-185% | -$14.06M-114% | ||
| $138.63M+7.6% | $155.51M+7.0% | $171.26M+105% | $101.9M+39.3% | $128.79M-4.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Precigen cover its short-term obligations?
- Its current ratio is 4.82 — current assets exceed current liabilities.
- Where does Precigen's balance sheet data come from?
- Every line is extracted from Precigen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.